Literature DB >> 10880897

[Role of antibiotic therapy in diabetic foot management].

A Hartemann-Heurtier1, L Marty, G Ha Van, A Grimaldi.   

Abstract

Antibiotic therapy is not the most important component in diabetic foot ulcer management which should be based on weight bearing avoidance and arterial revascularization. However antibiotic therapy is necessary in presence of extensive deep involvement or systemic signs of infection. Initial antimicrobial treatment depends on bacteria supposed origin. For patients not coming from hospital, the initial choice antibiotic is an amoxicillin/clavulanate agent because it offers optimal coverage for most pathogens involved in those diabetic foot lesions (gram positive cocci, gram negative and anaerobic organisms). For patients at high risk to be infected with nosocomially acquired pathogens, the initial antibiotic therapy must cover methicillin-resistant staphylococci, resistant pseudomonas aeruginosa or enterobacteriae. In all cases, when definitive reliable cultures are reported, initial antibiotic regimens should be revised to narrow the coverage to specific pathogens. In presence of osteomyelitis, a temporary combination of two agents which are known to reach high bone concentrations is necessary, and antibiotic therapy should be continued for at least two months. In other cases, antibiotic treatment duration depends on clinical out come.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880897

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  3 in total

Review 1.  Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment.

Authors:  Jorge Berlanga-Acosta
Journal:  Int Wound J       Date:  2011-09-13       Impact factor: 3.315

Review 2.  Optimising antimicrobial therapy in diabetic foot infections.

Authors:  Nalini Rao; Benjamin A Lipsky
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  [Principles of treatment for deep infections of the diabetic foot].

Authors:  S Kessler; P Delhey; C Volkering
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.